University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Nicholas Fidelman, M.D.

Interventional radiologist

Clinics

Radiology at Divisadero St.
1600 Divisadero St., Room A-142 and A-219
San Francisco, CA 94115
Scheduling: (415) 353-2573
CT, MRI and Bone Densitometry: (415) 885-7282
X-Ray and Nuclear Medicine:
(415) 885-3822
Interventional Radiology:
(415) 885-3578
Fax: (415) 353-7140

Hours: Monday to Friday,
8 a.m. – 5 p.m.

More about Nicholas Fidelman

Additional Languages

Russian

Education

UCSF School of Medicine 2002

Residencies

UCSF Medical Center, Radiology 2007

Fellowships

UCSF Medical Center, Inteventional Radiology 2008

Selected Research and Publications

  1. Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl. 2014 Oct; 20(10):1221-8.
  2. Kohi MP, Naeger DM, Lorenson MJ, Taylor AG, Kolli KP, Fidelman N, Kerlan RK. Hook, line, and sinker: hook wire localization of a retained suture needle in the perineum. J Vasc Interv Radiol. 2014 Sep; 25(9):1479-80.
  3. Fidelman N, Kerlan RK, Hawkins RA, Taylor AG, Kohi MP, Kolli KP, Bergsland EK, Kelley RK, Ko AH, Korn WM, McWhirter RM, Luan J, Venook AP. (90)Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study. J Gastrointest Cancer. 2014 Jun; 45(2):168-80.
  4. Price AJ, Fidelman N, Wilson MW, Kerlan RK. Percutaneous interventions in failing "necklace" hemodialysis grafts: long-term outcomes. J Vasc Interv Radiol. 2014 Feb; 25(2):199-205.
  5. Kuo YC, Kohi MP, Naeger DM, Tong RT, Kolli KP, Taylor AG, Laberge JM, Kerlan RK, Fidelman N. Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol. 2013 Oct; 36(5):1336-43.
  6. Veal DR, Lee AY, Kerlan RK, Gordon RL, Fidelman N. Outcomes of metallic biliary stent insertion in patients with malignant bilobar obstruction. J Vasc Interv Radiol. 2013 Jul; 24(7):1003-10.
  7. Kohi MP, Fidelman N, Kerlan RK. Reply to ?Re: Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?? J Vasc Interv Radiol. 2013 Jul; 24(7):1076.
  8. Olorunsola OG, Kohi MP, Fidelman N, LaBerge JM, Kerlan RK. Failure of filter reexpansion during unsuccessful retrieval of Option inferior vena cava filter. J Vasc Interv Radiol. 2013 Jul; 24(7):1065-7.
  9. Johnson DT, Durack JC, Fidelman N, Kerlan RK, LaBerge JM. Distribution of reported StarClose SE vascular closure device complications in the manufacturer and user facility device experience database. J Vasc Interv Radiol. 2013 Jul; 24(7):1051-6.
  10. Tong RT, Kohi M, Fidelman N, Kuo YC, Foster R, Peled A, Kolli KP, Taylor AG, LaBerge JM, Kerlan RK. Clinical outcomes of percutaneous drainage of breast fluid collections after mastectomy with expander-based breast reconstruction. J Vasc Interv Radiol. 2013 Sep; 24(9):1369-74.
  11. Ray CE, Lorenz JM, Burke CT, Darcy MD, Fidelman N, Greene FL, Hohenwalter EJ, Kinney TB, Kolbeck KJ, Kostelic JK, Kouri BE, Nair AV, Owens CA, Rochon PJ, Rockey DC, Vatakencherry G. ACR Appropriateness Criteria radiologic management of benign and malignant biliary obstruction. J Am Coll Radiol. 2013 Aug; 10(8):567-74.
  12. Kohi MP, Naeger DM, Kukreja J, Fidelman N, Laberge JM, Gordon RL, Kerlan RK. Preoperative CT-Guided percutaneous wire localization of ground glass pulmonary nodules with a modified Kopans wire. J Thorac Dis. 2013 Apr; 5(2):E31-4.
  13. Olorunsola OG, Kohi MP, Fidelman N, Westphalen AC, Kolli PK, Taylor AG, Gordon RL, LaBerge JM, Kerlan RK. Caval penetration by retrievable inferior vena cava filters: a retrospective comparison of Option and GŁnther Tulip filters. J Vasc Interv Radiol. 2013 Apr; 24(4):566-71.
  14. Wang SC, Fidelman N, Nakakura EK. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver. Semin Oncol. 2013 Feb; 40(1):69-74.
  15. Mehta N, Fidelman N, Sarkar M, Yao FY. Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2013 May; 11(5):572-8.
  16. Garwood ER, Fidelman N, Hoch SE, Kerlan RK, Yao FY. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction. Liver Transpl. 2013 Feb; 19(2):164-73.
  17. Arrayeh E, Fidelman N, Gordon RL, LaBerge JM, Kerlan RK, Klimov A, Bloom AI. Transcatheter arterial embolization for upper gastrointestinal nonvariceal hemorrhage: is empiric embolization warranted? Cardiovasc Intervent Radiol. 2012 Dec; 35(6):1346-54.
  18. Kouri BE, Funaki BS, Ray CE, Abou-Alfa GK, Burke CT, Darcy MD, Fidelman N, Greene FL, Harrison SA, Kinney TB, Kostelic JK, Lorenz JM, Nair AV, Nemcek AA, Owens CA, Saad WE, Vatakencherry G. ACR Appropriateness Criteria radiologic management of hepatic malignancy. J Am Coll Radiol. 2012 Dec; 9(12):919-25.
  19. Kohi MP, Fidelman N, Naeger DM, LaBerge JM, Gordon RL, Kerlan RK. Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong? J Vasc Interv Radiol. 2013 Jan; 24(1):68-73.
  20. Lee AY, Gregorius J, Kerlan RK, Gordon RL, Fidelman N. Percutaneous transhepatic balloon dilation of biliary-enteric anastomotic strictures after surgical repair of iatrogenic bile duct injuries. PLoS One. 2012; 7(10):e46478.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.